138 related articles for article (PubMed ID: 8366980)
1. Effect of hemodialysis on plasma levels of vasoactive peptides: endothelin, calcitonin gene-related peptide and human atrial natriuretic peptide.
Niwa T; Fujishiro T; Uema K; Tsuzuki T; Tominaga Y; Emoto Y; Miyazaki T; Maeda K
Nephron; 1993; 64(4):552-9. PubMed ID: 8366980
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive hormones in uremic patients on continuous ambulatory peritoneal dialysis.
Lai KN; Li PK; Woo KS; Lui SF; Leung JC; Law E; Nicholls MG
Clin Nephrol; 1991 May; 35(5):218-23. PubMed ID: 1830251
[TBL] [Abstract][Full Text] [Related]
3. Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia.
Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
ASAIO J; 1992; 38(3):M197-200. PubMed ID: 1281014
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
Ando R; Matsuda O; Miyake S; Yoshiyama N
Nephron; 1988; 50(3):225-8. PubMed ID: 2976122
[TBL] [Abstract][Full Text] [Related]
5. [A study on the relationship between plasma level of ET-1 and cGRP and blood pressure in hemodialysis patients].
Zhou Q; Sun M; Li X
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(4):335-7. PubMed ID: 9868091
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study.
Lightfoot BO; Caruana RJ
Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function.
Yamamoto Y; Higa T; Kitamura K; Tanaka K; Kangawa K; Matsuo H
Clin Nephrol; 1987 Feb; 27(2):84-6. PubMed ID: 2951044
[TBL] [Abstract][Full Text] [Related]
8. The radioimmunoassay for human plasma atrial natriuretic peptide--its application to uremic patients.
Nakagawa M; Shimamoto K; Yamaguchi Y; Masuda A; Saito S; Ando T; Watarai I; Sakurai H
Jpn J Med; 1987 Feb; 26(1):46-9. PubMed ID: 2952823
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma atrial natriuretic peptide and endothelin concentrations after surgery in patients with esophageal and gastric cancer.
Itoh K; Goseki N; Endo M; Marumo F
Bull Tokyo Med Dent Univ; 1996 Jun; 43(2):45-51. PubMed ID: 8826877
[TBL] [Abstract][Full Text] [Related]
10. [Calcitonin gene-related peptide and human atrial natriuretic hormone levels in response to cardiac operation under high dose fentanyl anesthesia].
Terazawa E; Shimonaka H; Oohata H; Ueda N; Ishizawa Y; Akamatsu S; Dohi S
Masui; 1995 Sep; 44(9):1202-7. PubMed ID: 8523650
[TBL] [Abstract][Full Text] [Related]
11. [Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients].
Witkowicz J; Kokot F; Irzyniec T; Chudek J; Ficek R
Pol Arch Med Wewn; 1999 Sep; 102(3):763-71. PubMed ID: 10949883
[TBL] [Abstract][Full Text] [Related]
12. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of HANP (human atrial natriuretic peptide) in patients on maintenance hemodialysis--HANP as a parameter to determine the dry weight (D.W.)].
Kuwahara M; Matsushita K; Yoshinaga H; Aki M; Fujisaki N; Kagawa S
Hinyokika Kiyo; 1992 Jan; 38(1):5-8. PubMed ID: 1532110
[TBL] [Abstract][Full Text] [Related]
14. Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients.
Ebihara I; Nakamura T; Takahashi T; Tomino Y; Shimada N; Koide H
Perit Dial Int; 1997; 17(6):595-601. PubMed ID: 9655160
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of plasma insulin and C-peptide levels with 3 different high-flux dialyzers in diabetic patients on hemodialysis.
Abe M; Okada K; Maruyama T; Inoshita A; Ikeda K; Uto E; Kikuchi F; Matsumoto K
Int J Artif Organs; 2008 Oct; 31(10):898-904. PubMed ID: 19009508
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of atrial natriuretic factor in normal children and patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
Yang LY; Chen WP; Lin CY
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(1):1-8. PubMed ID: 8333281
[TBL] [Abstract][Full Text] [Related]
17. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis.
Akizawa T; Kinugasa E; Koshikawa S
ASAIO Trans; 1991; 37(3):M384-5. PubMed ID: 1751199
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentration of uroguanylin in patients on maintenance dialysis therapy.
Fukae H; Kinoshita H; Fujimoto S; Nakazato M; Eto T
Nephron; 2000 Mar; 84(3):206-10. PubMed ID: 10720889
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of atrial natriuretic peptide in relation to body fluid status in chronic uraemia.
Cannella G; Rodella A; Brunori G; Gaggiotti M; Sandrini M; Maiorca R
Nephrol Dial Transplant; 1987; 2(3):158-60. PubMed ID: 2957617
[TBL] [Abstract][Full Text] [Related]
20. Plasma adrenomedullin levels in patients on hemodialysis.
Yamasaki H; Nagake Y; Akagi S; Sugimoto T; Ichikawa H; Makino H
Nephron; 2001 Sep; 89(1):20-5. PubMed ID: 11528227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
